55% of New York Covid fatalities had hypertension -
cardcrimson - 04-07-2020
Hypertension was by far the most common precondition among the fatalities at 55%, diabetes was second at 37%; 87% had some precondition. I'm sure someone is looking into a correlation with ACE inhibitors, but nothing has come out yet. As of a week ago, the AHA still considered them as not having any impact with Covid.
https://www.usatoday.com/story/news/health/2020/04/07/new-york-coronavirus-deaths-data-shows-most-had-underlying-illnesses/2960151001/
https://www.ahajournals.org/doi/10.1161/JAHA.120.016509
RE: 55% of New York Covid fatalities had hypertension -
oldalum - 04-07-2020
the prevalence of hypertension in the U.S. in adults is 45%; in the age group 45-64 it is 57%, and in people over 64 it is 77%.
cite
Since most of the deaths from Covid-19 occur in those over 44 years old, I don't think the 55% figure you cite in New York implies anything about whether the use of ACE inhibitors may contribute. The scientific speculation I've read goes both ways (some believe ACE inhibitors may be protective, others that it is the withdrawal of ACE inhibitor treatment that may be detrimental).
Only a more detailed analysis will tell.
RE: 55% of New York Covid fatalities had hypertension -
cardcrimson - 04-07-2020
(04-07-2020, 03:48 PM)oldalum Wrote: the prevalence of hypertension in the U.S. in adults is 45%; in the age group 45-64 it is 57%, and in people over 64 it is 77%. cite
Since most of the deaths from Covid-19 occur in those over 44 years old, I don't think the 55% figure you cite in New York implies anything about whether the use of ACE inhibitors may contribute. The scientific speculation I've read goes both ways (some believe ACE inhibitors may be protective, others that it is the withdrawal of ACE inhibitor treatment that may be detrimental). Only a more detailed analysis will tell.
Was more curious than anything. Have hypertension and was on an ACE inhibitor until a month ago. Blood pressure was okay on the new meds, until a spike today. Probably related to living with two females experiencing the opposite ends of the hormonal spectrums.
RE: 55% of New York Covid fatalities had hypertension -
M T - 04-07-2020
Did I already post this? Since I'm not sure, this retrospective, single-hospital study finds benefit for ACE Inhibitors & ARB. The report/study has not yet been peer reviewed.
Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors Usage is Associated with Improved Inflammatory Status and Clinical Outcomes in COVID-19 Patients With Hypertension
Quote:126 COVID-19 patients with preexisting hypertension at Hubei Provincial Hospital of Traditional Chinese Medicine (HPHTCM) in Wuhan from January 5 to February 22, 2020 were retrospectively allocated to ARBs/ACEIs group (n=43) and non-ARBs/ACEIs group (n=83) according to their antihypertensive medication. 125 age- and sex-matched COVID-19 patients without hypertension were randomly selected as non-hypertension controls.
Quote:Furthermore, much lower proportion of critical patients (9.3% vs 22.9%; p=0.061), and a lower death rate (4.7% vs 13.3%; p=0.216) were observed in ARBs/ACEIs group than non-ARBs/ACEIs group, although these differences failed to reach statistical significance.
The percentage of hypertension patients using ARB/ACEI was essentially the same among those infected with COVID-19 as those seen in a period before COVID-19 (34.1% vs 35.4%).
They see evidence that suggests inflammation response is involved, and suggest some specific studies be made.
RE: 55% of New York Covid fatalities had hypertension -
cardcrimson - 04-07-2020
Yes you did. However as the info out of China is allegedly suspect, I was curious if anyone had looked Covid deaths in NYC for any sort of link.
(04-07-2020, 05:32 PM)M T Wrote: Did I already post this? Since I'm not sure, this retrospective, single-hospital study finds benefit for ACE Inhibitors & ARB. The report/study has not yet been peer reviewed.
Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors Usage is Associated with Improved Inflammatory Status and Clinical Outcomes in COVID-19 Patients With Hypertension
Quote:126 COVID-19 patients with preexisting hypertension at Hubei Provincial Hospital of Traditional Chinese Medicine (HPHTCM) in Wuhan from January 5 to February 22, 2020 were retrospectively allocated to ARBs/ACEIs group (n=43) and non-ARBs/ACEIs group (n=83) according to their antihypertensive medication. 125 age- and sex-matched COVID-19 patients without hypertension were randomly selected as non-hypertension controls.
Quote:Furthermore, much lower proportion of critical patients (9.3% vs 22.9%; p=0.061), and a lower death rate (4.7% vs 13.3%; p=0.216) were observed in ARBs/ACEIs group than non-ARBs/ACEIs group, although these differences failed to reach statistical significance.
The percentage of hypertension patients using ARB/ACEI was essentially the same among those infected with COVID-19 as those seen in a period before COVID-19 (34.1% vs 35.4%).
They see evidence that suggests inflammation response is involved, and suggest some specific studies be made.
RE: 55% of New York Covid fatalities had hypertension -
oldalum - 04-07-2020
(04-07-2020, 05:21 PM)cardcrimson Wrote: Have hypertension and was on an ACE inhibitor until a month ago.
wife was on an ARB and another drug until a month ago, read the articles, talked to her doctor, dropped the ARB and doubled the other drug. Now her BP is better controlled and she's happy, which is a good outcome when you're making decisions in the absence of knowledge!
RE: 55% of New York Covid fatalities had hypertension -
M T - 04-11-2020
Another study, at least for those who can trust any non-US study, that found a beneficial association with ACE Inhibitor.
Currently in unreviewed preprint:
https://www.medrxiv.org/content/10.1101/2020.04.07.20056788v1
Don't change medication or dosages without your doctor's approval!
RE: 55% of New York Covid fatalities had hypertension -
akiddoc - 04-12-2020
(04-11-2020, 06:44 PM)M T Wrote: Another study, at least for those who can trust any non-US study, that found a beneficial association with ACE Inhibitor.
Currently in unreviewed preprint:
https://www.medrxiv.org/content/10.1101/2020.04.07.20056788v1
Don't change medication or dosages without your doctor's approval!
There is no reason to trust US studies more than foreign studies.
RE: 55% of New York Covid fatalities had hypertension -
burger - 04-12-2020
(04-11-2020, 06:44 PM)M T Wrote: Another study, at least for those who can trust any non-US study, that found a beneficial association with ACE Inhibitor.
Currently in unreviewed preprint:
https://www.medrxiv.org/content/10.1101/2020.04.07.20056788v1
Don't change medication or dosages without your doctor's approval!
Please ignore this study. Sample size in their group that reached the endpoint was FIVE on ACE inhibitors and FOUR on ARB. This is barely even science.